Shares of Diploma PLC (LON:DPLM – Get Free Report) reached a new 52-week high during trading on Wednesday . The stock traded as high as GBX 5,895 and last traded at GBX 5,835, with a volume of 2338822 shares traded. The stock had previously closed at GBX 5,030.
Wall Street Analyst Weigh In
A number of research analysts have weighed in on the company. Peel Hunt reissued a “buy” rating and set a GBX 6,150 price target on shares of Diploma in a research note on Friday, December 19th. Berenberg Bank reaffirmed a “buy” rating and issued a GBX 6,350 price objective on shares of Diploma in a research report on Wednesday, November 19th. Finally, Deutsche Bank Aktiengesellschaft upped their target price on Diploma from GBX 6,000 to GBX 6,200 and gave the company a “buy” rating in a research note on Wednesday, January 14th. Four research analysts have rated the stock with a Buy rating and three have assigned a Hold rating to the stock. According to MarketBeat.com, the company has an average rating of “Moderate Buy” and an average target price of GBX 5,634.29.
Check Out Our Latest Report on Diploma
Diploma Stock Up 17.3%
Insider Transactions at Diploma
In other news, insider Katie Bickerstaffe purchased 352 shares of the company’s stock in a transaction on Wednesday, January 14th. The stock was bought at an average cost of GBX 5,645 per share, for a total transaction of £19,870.40. Also, insider Ian El-Mokadem acquired 500 shares of the business’s stock in a transaction dated Wednesday, January 14th. The stock was purchased at an average price of GBX 5,615 per share, for a total transaction of £28,075. Over the last quarter, insiders acquired 1,262 shares of company stock valued at $6,995,830. Corporate insiders own 1.14% of the company’s stock.
Diploma Company Profile
Diploma PLC, together with its subsidiaries, supplies specialized technical products and services in the United Kingdom, Continental Europe, North America, and internationally. It operates through three business sectors: Life Sciences, Seals, and Controls. The Life Sciences sector supplies technology-enabled products used in surgical procedures in operating theatres and endoscopy; testing equipment and services for clinical laboratories; and bio-pharma, food safety and testing, and other research-oriented products.
Read More
Receive News & Ratings for Diploma Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Diploma and related companies with MarketBeat.com's FREE daily email newsletter.
